قد يعجبك
Acalabrutinib versus investigator's choice therapy in chronic lymphocytic leukemia - the ASCEND trial fal.cn/38xA8 #CLL #leusm #JCO
In this double-blind, randomized trial, 821 asymptomatic persons with a high- or moderate-risk exposure to #SARSCoV2 were assigned to receive hydroxychloroquine or placebo within 4 days after the exposure. No benefit in preventing illness compatible with #COVID19 was found.
ADAURA Establishes Adjuvant Osimertinib as a New Standard of Care for Early-Stage EGFR-Mutated #NSCLC fal.cn/38oWV #ASCODailyNews #LBA #ASCO20 @DrRoyHerbstYale @dave6408
Presenting the ADAURA data now @ASCO @ASCOPost at the plenary session. #ASCO20 The primary endpoint was met with DFS HR=0.17! Thank you to all the coinvestigators, study team & patients for participating in this practice changing study! @AstraZeneca @YaleCancer @Yale @LungMAP
United States الاتجاهات
- 1. Spotify 1.28M posts
- 2. Giannis 33.3K posts
- 3. #WhyIChime 1,297 posts
- 4. Chris Paul 43.9K posts
- 5. Clippers 59.5K posts
- 6. Bucks 24.5K posts
- 7. Hartline 15.3K posts
- 8. Milwaukee 12.1K posts
- 9. Ty Lue 6,005 posts
- 10. Merino 17.1K posts
- 11. Apple Music 229K posts
- 12. Madueke 10.2K posts
- 13. Trent 26.8K posts
- 14. Mike Lindell 3,413 posts
- 15. Ben White 4,345 posts
- 16. Jack Smith 26.1K posts
- 17. Mbappe 96.4K posts
- 18. SNAP 167K posts
- 19. #VoluMOASS N/A
- 20. Shams 2,085 posts
Something went wrong.
Something went wrong.